Thus it is likely that elevated expression of DUSP1/MKP-1 in tumours can mediate chemoresistance and this is supported by studies in non-small cell lung cancer (NSCLC) where overexpression of DUSP1/MKP-1 is observed and patients become resistant to treatment with cisplatin. Here, DUSP1 is linked to neoplasm.